543266 Stock Overview
Heranba Industries Limited manufactures, markets, and sells a range of agrochemicals in India.
543266 passed our risk checks.
Heranba Industries Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹564.35|
|52 Week High||₹836.45|
|52 Week Low||₹505.55|
|1 Month Change||-3.12%|
|3 Month Change||0.97%|
|1 Year Change||-29.72%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-30.52%|
Recent News & Updates
|543266||IN Chemicals||IN Market|
Return vs Industry: 543266 underperformed the Indian Chemicals industry which returned 10.6% over the past year.
Return vs Market: 543266 underperformed the Indian Market which returned 8.3% over the past year.
|543266 Average Weekly Movement||3.5%|
|Chemicals Industry Average Movement||6.3%|
|Market Average Movement||6.3%|
|10% most volatile stocks in IN Market||9.0%|
|10% least volatile stocks in IN Market||4.1%|
Stable Share Price: 543266 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 543266's weekly volatility (4%) has been stable over the past year.
About the Company
Heranba Industries Limited manufactures, markets, and sells a range of agrochemicals in India. The company provides intermediates, such as cypermethric acid chloride, high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and technical products, including cypermethrin, deltamethrin, alpha cypermethrin, acephate, lambda cyhalothrin, bifenthrin, and tranfluthrin, as well as tricyclazole, hexaconazole, tebuconazole, glyphosate, metribuzin, clodinafop, and bispyribac sodium. It also offers formulations comprising emulsifiable concentrate, water dispersible granule, suspension concentrate, capsule suspension, oil dispersion, concentrated aqueous emulsions, suspoemulsion, and zc formulation.
Heranba Industries Limited Fundamentals Summary
|543266 fundamental statistics|
Is 543266 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|543266 income statement (TTM)|
|Cost of Revenue||₹9.54b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||43.76|
|Net Profit Margin||11.99%|
How did 543266 perform over the long term?See historical performance and comparison